Zenox Lifesciences Limited, a under liquidation public limited company, was established on 23 June 2010 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51109TN2010PLC076261. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹14.00 Cr and a paid-up capital of ₹12.90 Cr.
It upholds a active non-compliant status. Its leadership includes Archana Aswathy (Director), Sundaram Nadar Arulrhaj (Managing Director), Saravanan (Whole-Time Director). Past directors included Archana Aswathy, Sundaram Nadar Arulrhaj, Mrithinjayam Anantharaman Sekaripuram. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 26 September 2014, with the balance sheet filed on 31 March 2014. It is based at 48/3/1, Muthukumarappa Street, Arcot Road, Saligramam,, Chennai, Tamil Nadu, 600093.
U51109TN2010PLC076261
076261
23 June 2010
₹14.00 Cr
₹12.90 Cr
Roc Chennai
Unlisted
Under Liquidation
Explore comprehensive insights into Zenox Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Aswathy | Director | 30 Jul 2011 | Current |
| Sundaram Nadar Arulrhaj | Managing Director | 01 Sep 2010 | Current |
| Saravanan | Whole-Time Director | 26 Sep 2014 | Current |
| Francis Victor Selvaraj Somiah | Director | 30 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Dec 2011 | Past |
| Pramod Abcsdd | Additional Director | 01 Dec 2011 | Past |
| Pramod Abcsdd | Director | 23 Jun 2010 | Past |
| Pramod Abcsdd | Additional Director | 08 Aug 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Jun 2011 | Past |
| Pramod Abcsdd | Whole-Time Director | 31 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Zenox Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Zenox Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2012 | State Bank Of India | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Zenox Lifesciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zenox Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenox Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Zenox Lifesciences Limited last Annual general meeting of members was held on 26 Sep 2014 as per latest MCA records. was recorded as a recent event.
Saravanan was appointed as a Whole-time director was appointed as a Whole-time director on 26 Sep 2014 & has been associated with this company since 11 years 2 months . was recorded as a recent event.
Zenox Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Chennai. was recorded as a recent event.
A charge with State Bank Of India amounted to Rs. 1.00 Cr with Charge ID 10391627 was registered on 25 Oct 2012. was recorded as a recent event.
Progress on Archana Aswathy was appointed as a Director was appointed as a Director on 30 Jul 2011 & has been associated with this company since 14 years 4 months . was documented.
The activity Francis Victor Selvaraj Somiah was appointed as a Director was appointed as a Director on 30 Jul 2011 & has been associated with this company since 14 years 4 months . was completed.
The CIN of Zenox Lifesciences Limited is U51109TN2010PLC076261.
Zenox Lifesciences Limited is headquartered at 48/3/1, Muthukumarappa Street, Arcot Road, Saligramam,, Chennai, Tamil Nadu, 600093.
Zenox Lifesciences Limited was incorporated on 23 June 2010.
The current directors of Zenox Lifesciences Limited are
The primary industry of Zenox Lifesciences Limited is Pharma.
Zenox Lifesciences Limited is unlisted.
The authorized capital of Zenox Lifesciences Limited is ₹14.00 Cr, and the paid-up capital is ₹12.90 Cr.
The compliance status of Zenox Lifesciences Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX